की कीमत क्या है D. Western Therapeutics Institute, Inc. (4576)

का मूल्य D. Western Therapeutics Institute, Inc. (4576) है $0.5676202

का बाजार पूंजीकरण क्या है D. Western Therapeutics Institute, Inc. (4576)

का बाजार पूंजीकरण D. Western Therapeutics Institute, Inc. (4576) है $32.62M

D. Western Therapeutics Institute, Inc. (4576) P/S अनुपात

D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.

वर्ष	P/S अनुपात	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

P/S अनुपात

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

कंपनी	P/S अनुपात	P/S अनुपात में अंतर	देश
Vertex Pharmaceuticals Incorporated VRTX.US	10.17	-	US
Moderna, Inc. MRNA.US	11.28	-	US
Argenx SE ARGX.US	10.13	-	NL
CSL Limited CSL.AX	2.95	-	AU
Lonza Group AG LONN.SW	-	-	CH

कंपनी

P/S अनुपात

P/S अनुपात में अंतर

देश